Integrated Health Maintenance Reminders for Improved HPV Vaccine Administration: Toward Improvements in Completion Disparities

Overview

Journal Otolaryngol Head Neck Surg

Publisher Wiley

Specialties General Surgery
Otorhinolaryngology

Date 2023 Mar 20

PMID 36939623

Authors

Jess D Rames

Nicholas A Frisco

Rong Jiang

Kevin P Shah

Russel R Kahmke

Liana Puscas

Nosayaba Osazuwa-Peters

Daniel J Rocke

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the effect of a health maintenance reminder (HMR) on human papillomavirus (HPV) vaccine administration and completion across different age, insurance, and race cohorts.

Study Design: Retrospective pre-post analysis.

Setting: Academic primary care.

Methods: Patients aged 9 to 26 who had initiated the HPV vaccine series from 2016 to 2021 were analyzed, based on current age-based standards. The cohort was divided based on vaccine uptake before and after the implementation of the HMR program in February 2020. The multivariate analysis estimated the odds of vaccine completion based on sociodemographic factors, and variable interactions were investigated to determine independent associations between sociodemographic factors and HMR implementation.

Results: There were 7654 individual patients (mean age was 15.8 years; 46.7 were males; and 50.7% were white). HPV vaccine completion rates increased post-HMR implementation by 59.2% (37% pre-, and 58.9% post-HMR; p < .001) in the entire cohort. Overall, black patients (adjusted odds ratio [aOR] = 0.68; 95% confidence interval [CI]: 0.60, 0.70) and patients ≥18 years (aOR = 0.13; 95% CI: 0.11, 0.15) were significantly less likely to complete their vaccine series; however, this improved significantly following HMR in these groups (p < .001). Post-HMR, race, and insurance status were not independently associated with disparate vaccine completion rates, however, age was, and patients ≤14 or younger had higher odds of vaccine completion (aOR = 3.54; 95% CI: 2.91, 4.32).

Conclusion: The implementation of an HMR was associated with increased HPV vaccine uptake across age and race groups in this single-institution study. Future research should explore barriers to implementing HMRs in different health care settings.

References

Kim J . Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis. 2010; 10(12):845-52. PMC: 3982926. DOI: 10.1016/S1473-3099(10)70219-X. View

Shew M, Shew M, Bur A . Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer. Hum Vaccin Immunother. 2018; 15(7-8):1929-1934. PMC: 6746502. DOI: 10.1080/21645515.2018.1526559. View

Dorell C, Yankey D, Strasser S . Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009. Clin Pediatr (Phila). 2011; 50(12):1116-24. DOI: 10.1177/0009922811415104. View

Adjei Boakye E, Tobo B, Rojek R, Mohammed K, Geneus C, Osazuwa-Peters N . Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017; 13(11):2713-2722. PMC: 5703403. DOI: 10.1080/21645515.2017.1363133. View

Spencer J, Brewer N, Trogdon J, Wheeler S, Dusetzina S . Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health. 2018; 108(7):946-950. PMC: 5993378. DOI: 10.2105/AJPH.2018.304408. View

Jeudin P, Liveright E, Carmen M, Perkins R . Race, ethnicity and income as factors for HPV vaccine acceptance and use. Hum Vaccin Immunother. 2013; 9(7):1413-20. DOI: 10.4161/hv.24422. View

Fiks A, Grundmeier R, Mayne S, Song L, Feemster K, Karavite D . Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013; 131(6):1114-24. PMC: 3666111. DOI: 10.1542/peds.2012-3122. View

Mansfield L, Chung R, Silva S, Merwin E, Gonzalez-Guarda R . Social determinants of human papillomavirus vaccine series completion among U.S. adolescents: A mixed-methods study. SSM Popul Health. 2022; 18:101082. PMC: 9038569. DOI: 10.1016/j.ssmph.2022.101082. View

Agawu A, Hanlon A, Buttenheim A, Song L, Fiks A, Feemster K . Disparities in Human Papillomavirus Vaccine Series Completion by Adolescent Males: A Retrospective Cohort Study. Acad Pediatr. 2019; 20(3):364-373. DOI: 10.1016/j.acap.2019.05.002. View

10.

Pingali C, Yankey D, Elam-Evans L, Markowitz L, Williams C, Fredua B . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(35):1183-1190. PMC: 8422873. DOI: 10.15585/mmwr.mm7035a1. View

11.

Berenson A, Hirth J, Kuo Y, Starkey J, Rupp R . Use of patient navigators to increase HPV vaccination rates in a pediatric clinical population. Prev Med Rep. 2020; 20:101194. PMC: 7490555. DOI: 10.1016/j.pmedr.2020.101194. View

12.

Adjei Boakye E, Lew D, Muthukrishnan M, Tobo B, Rohde R, Varvares M . Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States. Hum Vaccin Immunother. 2018; 14(8):2016-2024. PMC: 6150015. DOI: 10.1080/21645515.2018.1467203. View

13.

Bramer C, Kimmins L, Swanson R, Kuo J, Vranesich P, Jacques-Carroll L . Decline in child vaccination coverage during the COVID-19 pandemic - Michigan Care Improvement Registry, May 2016-May 2020. Am J Transplant. 2020; 20(7):1930-1931. PMC: 7361263. DOI: 10.1111/ajt.16112. View

14.

Bae J, Ford E, Wu S, Huerta T . Electronic reminder's role in promoting human papillomavirus vaccine use. Am J Manag Care. 2017; 23(11):e353-e359. View

15.

Hirth J . Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2018; 15(1):146-155. PMC: 6363146. DOI: 10.1080/21645515.2018.1512453. View

16.

Fiks A, Grundmeier R, Biggs L, Russell Localio A, Alessandrini E . Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics. 2007; 120(4):707-14. DOI: 10.1542/peds.2007-0257. View

17.

Cook R, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H . Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010; 47(6):596-9. DOI: 10.1016/j.jadohealth.2010.09.015. View

18.

Tan W, Viera A, Rowe-West B, Grimshaw A, Quinn B, Walter E . The HPV vaccine: are dosing recommendations being followed?. Vaccine. 2011; 29(14):2548-54. DOI: 10.1016/j.vaccine.2011.01.066. View

19.

Widdice L, Bernstein D, Leonard A, Marsolo K, Kahn J . Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2010; 127(1):77-84. PMC: 3010090. DOI: 10.1542/peds.2010-0812. View

20.

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View